Zotefoams plc In line with long-term strategy and further growth

Foam

Zotefoams plc (LON: ZTF), a world leader in cellular materials technology, today provided a trading update following the Company’s financial year end on 31 December 2019.

Trading conditions in the final quarter were largely as anticipated with the result that full year Group revenue will be at a similar level to 2018. For the financial year, business units performed as follows:

· c20% increase in High Performance Products (“HPP”) sales;

· c60% increase in MuCell Extrusion LLC (“MEL”) sales and;

· c10% decline in Polyolefin sales, reflecting challenging market conditions in the second half of the year.

In the final quarter of the year profitability was ahead of management expectations prior to an adverse impact from foreign exchange rate movements. From the date of our last announcement on 3 October until 31 December 2019 sterling appreciation resulted in an adverse foreign exchange impact, for this period alone, on Group profit before tax of ÂŁ0.8m. Of this, ÂŁ0.6m related to the non-cash translation impact of intra-group loans. The Group therefore expects to report, subject to audit, adjusted profit before tax and exceptional item* for the year ended 31 December 2019 of approximately ÂŁ9.1m.

All major capital projects were either completed during the year or are expected to complete in 2020 on time and on budget.

The Company expects to announce preliminary results for the year ended 31 December 2019 on Tuesday 24 March 2020.

Commenting on the update David Stirling, Group CEO of Zotefoams, said:

While market conditions during the year have been challenging for our Polyolefins business, we expect to see a recovery in 2020. In line with our long-term strategy we expect to deliver further growth in our HPP and MEL business units.

Due to the current market conditions, recently commissioned long-term capacity investments are expected to run at low utilisation rates, with depreciation and other costs being under recovered in the short term. These investments are consistent with the opportunity and ambition of Zotefoams and, with the anticipated recovery in the markets for Polyolefin foams and further growth from HPP, we expect improved utilisation of these assets in the latter part of 2020.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:

Latest Company News

Zotefoams update strengthens the investment case

Zotefoams’ latest update shows a stronger, broader growth business than the current valuation appears to recognise.

Zotefoams reports strong start to 2026 with revenue up 26%

Zotefoams reported revenue of £64.1 million for the four months to 30 April 2026, driven by strong demand, OKC’s contribution, and growth in North America and Asia. Full-year expectations remain unchanged.

Zotefoams adds sales leadership to support growth targets

Zotefoams has strengthened its EMEA and North American sales teams as it targets higher revenue and operating profit by FY29.

Zotefoams outlines 2025 financial performance and sets 2026 AGM

Zotefoams plc has released its 2025 Annual Report, detailing full-year financial performance and management commentary, including reviews from the Chair, Group CEO and CFO.

Zotefoams reports record FY2025 profits and margin growth

Zotefoams plc posted record revenue of ÂŁ158.5m and a 26% rise in adjusted operating profit to ÂŁ22.8m for FY2025, supported by strong cash generation and strategic investment.

Zotefoams reports record profits and 7.2% revenue growth for FY2025

Zotefoams expects full-year revenue of ÂŁ158.5m for the year ended 31 December 2025, up 7.2% year on year and ahead of market expectations.

    Search